Immuneering Corporation IMRX
3.37 USD -0.39 (-10.37%)
At closeNov 6, 2026, 7:00 AM EST
3.50 +0.13 +3.86%
Pre-market · Nov 6, 7:00 AM ET
3.35 Day range 3.74
3.35 52-week range 8.48
- YTD
- -48.78%
- 1 year
- -49.09%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -59.38M | -64.07M | -58.41M | -51.74M | -33.89M | |
| -56.02M | -61.04M | -53.47M | -50.51M | -33.54M | |
| -1.27 | -2.04 | -1.88 | -1.91 | -2.46 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 128.65M | 36.14M | 59.41M | 72.64M | 74.89M | |
| 231.99M | 52.71M | 102.58M | 122.37M | 166.70M | |
| 13.50M | 11.33M | 12.01M | 12.52M | 10.72M | |
| 3.82M | 4.16M | 4.46M | 4.84M | 5.36M | |
| 218.48M | 41.39M | 90.58M | 109.85M | 155.98M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -45.34M | -55.00M | -48.97M | -44.10M | -30.85M | |
| -88.74M | 26.43M | 7.30M | 41.83M | -75.62M | |
| 226.58M | 5.30M | 28.44M | 19.00K | 144.26M | |
| -142.23K | -84.88K | -342.75K | -742.48K | -60.79K | |
| 92.50M | -23.26M | -13.23M | -2.25M | 37.80M |